Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.53 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.53 |
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.51 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.51 |
| ▸ | KIF11 | P52732 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | GFER | P55789 | 1/20 | 0.44 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.44 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14073502 | 0.91 | KMT2A (0.65) | KMT2ATRPV1CYP2C9TMIGD3ADORA1 | |
| SCHEMBL30444601 | 0.84 | KMT2A (0.62) | KMT2ACYP3A4CYP19A1TRPV1CYP2C9 | |
| SCHEMBL14073749 | 0.80 | NPC1 (0.55) | KMT2ACYP3A4CYP19A1TRPV1CYP2C9 | |
| SCHEMBL14073778 | 0.80 | CYP3A4 (0.61) | KMT2ACYP3A4CYP19A1TRPV1CYP2C9 | |
| SCHEMBL14073692 | 0.78 | ALDH1A1 (0.72) | KMT2ACYP3A4CYP19A1TRPV1CYP2C9 | |
| SCHEMBL14073821 | 0.78 | KMT2A (0.55) | KMT2ACYP3A4CYP19A1TRPV1CYP2C9 | |
| SCHEMBL14073735 | 0.78 | KMT2A (0.61) | KMT2ACYP3A4CYP19A1TRPV1CYP2C9 | |
| SCHEMBL14073772 | 0.78 | NPC1 (0.61) | KMT2ACYP3A4CYP19A1TRPV1CYP2C9 | |
| SCHEMBL14073923 | 0.77 | CYP3A4 (0.54) | KMT2ACYP3A4CYP19A1TRPV1CYP2C9 | |
| SCHEMBL4578101 | 0.77 | TRPV1 (0.56) | KMT2ACYP3A4CYP19A1TRPV1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080221093-A1 | Metalloprotease inhibitors containing a heterocyclic moiety | ALANTOS PHARMACEUTICALS HOLDING, INC. | 2008-09-11 | — | — | US | disclosed |
| US-20080221093-A1 | Metalloprotease inhibitors containing a heterocyclic moiety | ALANTOS PHARMACEUTICALS HOLDING, INC. | 2008-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221093-A1 | Metalloprotease inhibitors containing a heterocyclic moiety | MMP12, MMP13, MMP25 | KMT2A 2900/4885CYP3A4 376/4885CYP19A1 651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.